Does EZETIMIBE\ROSUVASTATIN Cause Myalgia? 58 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Myalgia have been filed in association with EZETIMIBE\ROSUVASTATIN. This represents 17.6% of all adverse event reports for EZETIMIBE\ROSUVASTATIN.
58
Reports of Myalgia with EZETIMIBE\ROSUVASTATIN
17.6%
of all EZETIMIBE\ROSUVASTATIN reports
0
Deaths
9
Hospitalizations
How Dangerous Is Myalgia From EZETIMIBE\ROSUVASTATIN?
Of the 58 reports, 9 (15.5%) required hospitalization, and 1 (1.7%) were considered life-threatening.
Is Myalgia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\ROSUVASTATIN. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE\ROSUVASTATIN Cause?
Acute kidney injury (24)
Arthralgia (17)
Blood creatine phosphokinase increased (17)
Leriche syndrome (16)
Muscle spasms (16)
Peripheral arterial occlusive disease (16)
Asthenia (14)
Drug abuse (14)
Hepatic cytolysis (12)
Metabolic acidosis (12)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
EVOLOCUMAB (5,061)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
Which EZETIMIBE\ROSUVASTATIN Alternatives Have Lower Myalgia Risk?
EZETIMIBE\ROSUVASTATIN vs EZETIMIBE\SIMVASTATIN
EZETIMIBE\ROSUVASTATIN vs EZOGABINE
EZETIMIBE\ROSUVASTATIN vs FACTOR XIII CONCENTRATE
EZETIMIBE\ROSUVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI
EZETIMIBE\ROSUVASTATIN vs FAMCICLOVIR